GlassScriptPhysician profile
Alan J Bacho
NPI 1235296609
$3,271.58
in general payments reported to CMS, 2019-2025
13 companies · $384 in 2025
The $384 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $140 · 2021: $762 · 2022: $898 · 2023: $461 · 2024: $277 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,121.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,665.51 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $674.58 | 2019-2023 | Total30, Precision 1 |
| Bausch & Lomb Americas INC. | $345.49 | 2022-2025 | Infuse, Miebo, Biotrue |
| Coopervision INC. | $162.78 | 2020-2025 | Clariti Contact Lens |
| Sun Pharmaceutical Industries INC. | $124.25 | 2021 | |
| Maculogix, INC. | $97.23 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $87.06 | 2019-2021 | |
| Abb Con-Cise Optical Group LLC | $37.48 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $29.79 | 2021 | |
| Eyevance Pharmaceuticals LLC | $14.81 | 2022 | |
| Kala Pharmaceuticals, INC. | $13.76 | 2021 | |
| Shire North American Group INC | $12.53 | 2019 | |
| Optos, INC. | $6.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Bacho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.